Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Hum Mutat. 2020 Jul 5;41(9):1528–1539. doi: 10.1002/humu.24065

Table 2:

Participants with p.Arg172Trp Variant

Family code Diagnosis Age y Age of onset y BCVA logMAR OD BCVA logMAR OS ERG Response Fundus Appearance
12.1 PD 52 32 +0.60 +0.18 N OU: Depigmented lesion in fovea, central hypofluorescence surrounded by hyperfluorescence by FA, foveal atrophy, ‘questionable dark choroid’ by FA
12.2 PD 26 26 −0.12 0.00 ND OU: Depigmented lesion in fovea, Hyperpigmentation, Central hypofluorescence surrounded by hyperfluorescence by FA
22 BD 56 20 +1.30 +1.30 ND OU: Scar/atrophy
72 CRD 12 12 −0.10 0.00 ND OU: Macular degeneration, granular macular pigmentation, Bull’s eye pattern w/hypopigmented parafovea, normal OCT thickness
73.1 CRD 56 15 +1.00 +1.30 A OU: Macular degeneration, vascular attenuation
73.2 CRD 60 36 +0.30 +0.30 A OU: Macular degeneration
73.3 CRD 38 38 +0.30 +0.10 A OU: Macular degeneration, central choroidal show
73.4 CRD 63 30 +1.30 +1.20 ND OU: Macular degeneration, vascular attenuation
74 PD 56 55 0.00 +0.10 ND OU: Depigmented lesion in fovea
75 RP 46 24 +2.00 +2.00 ND OU: Retinal degeneration, intraretinal pigment spicules, macular degeneration, peripheral retinal degeneration, vascular attenuation
127 CRD 49 41 +0.30 +0.18 A OU: Macular degeneration
133 RP 58 20 +0.70 +3.00 ND OU: Retinal degeneration, intraretinal pigment spicules, vascular attenuation
144 SD 15 11 +0.48 +1.00 ND OU: Macular degeneration, vascular attenuation

Age at exam in years (y); Reported age of onset in years (y); PD-Pattern dystrophy, BD-Best disease, CRD-Cone rod dystrophy, RP-Retinitis pigmentosa, SD-Stargardt disease; Full-field ERG response N-Normal, A-Abnormal, ND-Not done